TXNIP and type 2 diabetes mellitus: A recent large meta-EWAS of prevalent T2D in a European population, using peripheral blood DNA methylation, confirmed three previously identified CpG sites at TXNIP, ABCG1, and CPT1A, and also reported three novel CpG sites associated with prevalent T2D among Europeans, namely cg00144180 (HDAC4), cg16765088 (near SYNM) and cg24704287 (near MIR23A) [34].